Kanji, S <br/><br/>
Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis.  [electronic resource] 

 -  Pharmacotherapy  Nov 2001 
 - 1389-402 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0277-0008 
<br/><br/><label>Standard No.: </label>10.1592/phco.21.17.1389.34417  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Fibrinolytic Agents--adverse effects<br/>Humans<br/>Protein C--adverse effects<br/>Recombinant Proteins--adverse effects<br/>Sepsis--drug therapy